Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Dupont

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapyAisha N Hasan, Wouter J Kollen, Deepa Trivedi, et al.
Pediatric Diabetes|January 5, 2006
Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitusEric I Felner, William Klitz, Melissa Ham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2009
The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptorsBryan M Burt, George Plitas, Zeguo Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinomaEkaterina S Doubrovina, Mikhail M Doubrovin, Elena Vider, et al.
Blood|February 4, 2010
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantationJeffrey M Venstrom, Ted A Gooley, Stephen Spellman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2009
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoireGilles Bioley, Christelle Dousset, Alice Yeh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosisIlijas Jelcić, Katharine C Hsu, Kristina Kakalacheva, et al.
Immunity|August 7, 2016
Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class IJeanette E Boudreau, Xiao-Rong Liu, Zeguo Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccineGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2013
NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligandGianfranco Pittari, Xiao-Rong Liu, Annamalai Selvakumar, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapyAisha N Hasan, Wouter J Kollen, Deepa Trivedi, et al.
Pediatric Diabetes|January 5, 2006
Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitusEric I Felner, William Klitz, Melissa Ham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2009
The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptorsBryan M Burt, George Plitas, Zeguo Zhao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinomaEkaterina S Doubrovina, Mikhail M Doubrovin, Elena Vider, et al.
Blood|February 4, 2010
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantationJeffrey M Venstrom, Ted A Gooley, Stephen Spellman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2009
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoireGilles Bioley, Christelle Dousset, Alice Yeh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2011
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosisIlijas Jelcić, Katharine C Hsu, Kristina Kakalacheva, et al.
Immunity|August 7, 2016
Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class IJeanette E Boudreau, Xiao-Rong Liu, Zeguo Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccineGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2013
NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligandGianfranco Pittari, Xiao-Rong Liu, Annamalai Selvakumar, et al.
Pageof 4